-
公开(公告)号：US10071146B2
公开(公告)日：2018-09-11
申请号：US15030678
申请日：2014-10-20
发明人： Satoshi Fukaya , Toshihiro Osada , Hiroshi Wada
摘要： This invention provides a cancer antigen peptide that can be administered to a wide range of cancer patients in the form of a peptide vaccine for cancer without the need for HLA typing and regardless of the HLA types of patients. Such peptide having 4 linked CTL epitopes is obtained by linking 4 CTL epitope peptides selected from among CTL epitope peptides derived from tumor antigen molecules that are reported to have the capacity for CTL induction via linkers.
-
公开(公告)号：US09701729B2
公开(公告)日：2017-07-11
申请号：US14773140
申请日：2014-03-05
发明人： Satoshi Fukaya , Toshihiro Osada , Hiroshi Wada , Teruhiro Utsugi
CPC分类号： C07K14/4748 , A61K39/0011 , A61K2039/572 , A61K2039/70 , C07K14/82 , C07K2319/00 , C07K2319/33
摘要： This invention provides a cancer antigen peptide that can be administered to a wide range of cancer patients in the form of a peptide vaccine for cancer without the need for HLA typing and regardless of the HLA types of patients. Such peptide having 5 linked CTL epitopes is obtained by linking 5 CTL epitope peptides selected from among CTL epitope peptides derived from tumor antigen molecules that are reported to have the capacity for CTL induction via linkers.
-
公开(公告)号：US10137183B2
公开(公告)日：2018-11-27
申请号：US15030678
申请日：2014-10-20
发明人： Satoshi Fukaya , Toshihiro Osada , Hiroshi Wada
摘要： This invention provides a cancer antigen peptide that can be administered to a wide range of cancer patients in the form of a peptide vaccine for cancer without the need for HLA typing and regardless of the HLA types of patients. Such peptide having 4 linked CTL epitopes is obtained by linking 4 CTL epitope peptides selected from among CTL epitope peptides derived from tumor antigen molecules that are reported to have the capacity for CTL induction via linkers.
-
-
搜索结果
3 条记录 (耗时 0.017 秒)
